|
CCNT2 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.576670E-04 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.25090000000639E-05 |
| Normal-vs-Stage2 |
1.774280E-02 |
| Normal-vs-Stage3 |
7.776500E-03 |
| Normal-vs-Stage4 |
2.190400E-01 |
| Stage1-vs-Stage2 |
7.552000E-01 |
| Stage1-vs-Stage3 |
5.811400E-01 |
| Stage1-vs-Stage4 |
2.079600E-02 |
| Stage2-vs-Stage3 |
5.238800E-01 |
| Stage2-vs-Stage4 |
1.145790E-01 |
| Stage3-vs-Stage4 |
1.541220E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.614800E-04 |
| Normal-vs-AfricanAmerican |
1.774090E-02 |
| Normal-vs-Asian |
5.98419999999766E-05 |
| Caucasian-vs-AfricanAmerican |
9.141600E-01 |
| Caucasian-vs-Asian |
5.258100E-02 |
| AfricanAmerican-vs-Asian |
4.397800E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.641300E-03 |
| Normal-vs-Female |
1.70780999999565E-05 |
| Male-vs-Female |
3.860200E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.455200E-01 |
| Normal-vs-Age(41-60Yrs) |
4.15900000000358E-05 |
| Normal-vs-Age(61-80Yrs) |
4.775900E-03 |
| Normal-vs-Age(81-100Yrs) |
2.122800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.690800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.116400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.590000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.332600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.358600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.970800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.773610E-04 |
| Normal-vs-Grade 2 |
1.19009999999253E-06 |
| Normal-vs-Grade 3 |
1.547640E-02 |
| Normal-vs-Grade 4 |
8.841200E-01 |
| Grade 1-vs-Grade 2 |
2.713400E-01 |
| Grade 1-vs-Grade 3 |
2.218100E-02 |
| Grade 1-vs-Grade 4 |
3.019500E-03 |
| Grade 2-vs-Grade 3 |
2.403000E-03 |
| Grade 2-vs-Grade 4 |
6.1332000000025E-05 |
| Grade 3-vs-Grade 4 |
5.233700E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
2.69830000010352E-07 |
| Normal-vs-ccB subtype |
1.650420E-02 |
| ccA subtype-vs-ccB subtype |
6.021700E-03 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.420570E-04 |
| Normal-vs-N1 |
9.673000E-01 |
| N0-vs-N1 |
1.440040E-01 |
|
|
